Details of the Drug
General Information of Drug (ID: DMDW8VX)
Drug Name |
N-(1,3-diphenyl-1H-pyrazol-5-yl)benzamide
|
||||||||||||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Synonyms |
N-(1,3-diphenyl-1H-pyrazol-5-yl)benzamide; CHEMBL191039; 77746-90-8; N-(2,5-diphenylpyrazol-3-yl)benzamide; AC1N4KII; Oprea1_790904; SCHEMBL2482825; CTK2G6100; DTXSID00400046; MolPort-003-805-392; HMS3519K01; ZINC3185886; BDBM50156065; AKOS005002190; MCULE-3316862201; DA-03411; FT-0732104; N-(1,3-Diphenyl-1H-pyrazole-5-yl)benzamide; N-(2,5-Diphenyl-2H-pyrazol-3-yl)-benzamide; Benzamide, N-(1,3-diphenyl-1H-pyrazol-5-yl)-
|
||||||||||||||||||||||
Indication |
|
||||||||||||||||||||||
Drug Type |
Small molecular drug
|
||||||||||||||||||||||
Structure | |||||||||||||||||||||||
3D MOL | 2D MOL | ||||||||||||||||||||||
#Ro5 Violations (Lipinski): 0 | Molecular Weight (mw) | 339.4 | |||||||||||||||||||||
Logarithm of the Partition Coefficient (xlogp) | 4.7 | ||||||||||||||||||||||
Rotatable Bond Count (rotbonds) | 4 | ||||||||||||||||||||||
Hydrogen Bond Donor Count (hbonddonor) | 1 | ||||||||||||||||||||||
Hydrogen Bond Acceptor Count (hbondacc) | 2 | ||||||||||||||||||||||
Chemical Identifiers |
|
||||||||||||||||||||||
Cross-matching ID | |||||||||||||||||||||||
Molecular Interaction Atlas of This Drug
Drug Therapeutic Target (DTT) |
|
||||||||||||||||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Molecular Interaction Atlas (MIA) | |||||||||||||||||||||||||||
Molecular Expression Atlas of This Drug
The Studied Disease | Discovery agent | |||||||||||||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
ICD Disease Classification | N.A. | |||||||||||||||||||||||
|
||||||||||||||||||||||||
Molecular Expression Atlas (MEA) | ||||||||||||||||||||||||